Michael Boivin
banner
commpharm.bsky.social
Michael Boivin
@commpharm.bsky.social
Pharmacist and CHE Developer. Proud Canadian with an interest in learning about every clinical topic. Special focus in Endocrinology, immunology (vaccines), obesity, CVD, rheumatology, and travel medicine.
New Acute Migraine Management Guidelines:
- Triptans combined with NSAIDs (e.g., sumatriptan + naproxen) offer the highest net benefit
- Triptan + acetaminophen is also beneficial.
- Monotherapies are effective, but less so than combination therapy.
www.acpjournals.org/doi/10.7326/...
April 15, 2025 at 1:11 PM
New Rheumatology guideline on Sjogren Disease - Wicked condition for affected patients, for my specialty colleagues, worth a quick read.

academic.oup.com/rheumatology...
January 31, 2025 at 12:26 PM
Physical activity and weight loss - Common question at this time of year. Moderate weight loss for aerobic exercise. Key findings:

- Each 30-minute increase in weekly aerobic exercise leads to measurable reductions in weight, waist circumference, and body fat.

jamanetwork.com/journals/jam...
January 6, 2025 at 4:50 PM
Managing GLP-1 RA GI-related adverse effects - Common question, new review. Some new tips for your patients. #diabetes, #obesity, #GLP-1RA

www.dovepress.com/dietary-reco...
December 28, 2024 at 4:12 PM
Pediatric influenza vaccine effectiveness Study - We know that 6 months to 5 years is a high-risk group of influenza-related complications. The vaccine reduced the risk of ED visits, noncritical and critical influenza by about 50%. Really supports use in this group.
jamanetwork.com/journals/jam...
December 28, 2024 at 4:11 PM
Dysplipidemia manage - "Lower is better for longer and the earlier the better"

rdcu.be/d33UT
December 18, 2024 at 6:29 PM
New Innovative review of Glucagon-based Therapies for Obesity Management - Current and future therapies for the management of obesity academic.oup.com/jes/article/...
November 22, 2024 at 2:21 PM
New Canadian Diabetes Pharmacotherapy Guidelines in Type 2 diabetes. Updated for 2024.

www.canadianjournalofdiabetes.com/article/S149...
November 17, 2024 at 3:23 PM